Changing the course of autoimmune disease

Inspired by patients. Driven to make an impact.

Latest News

August 4, 2022 • 6:00am EDT

Aurinia Reports Second Quarter and Six Months 2022 Financial and Operational Results

Read Press Release View All News

August 1, 2022 • 4:05pm EDT

Aurinia Reports New Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Read Press Release View All News

July 26, 2022 • 2:00pm EDT

Aurinia Pharmaceuticals Notification Regarding Inter Partes Patent Review

Read Press Release View All News